HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status. (2016)
Attributed to:
King’s College London Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.9963
PubMed Identifier: 27618787
Publication URI: http://europepmc.org/abstract/MED/27618787
Type: Journal Article/Review
Volume: 7
Parent Publication: Oncotarget
Issue: 32
ISSN: 1949-2553